Savvy Wealth
Savvy Wealth gives independent financial advisors an operating platform that combines practice tools, investment support and AI-assisted client work.
$100MSeries C
ParticipantEC
Euclidean Capital
Activity from announced rounds
Activity in this selectionUnited States · Oct 15, 2026 · Jul 18, 2026
- Rounds participated in
- 5
- Confirmed lead rounds
- 0 2 roles undisclosed
- New companies
- 4 First participation on record · 1 follow-on
- Funding in participating rounds
- $399.5M 5 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
5 in this selectionCircle Pharma, Inc.
Circle Pharma discovers macrocycle medicines for cancer and other serious diseases using its MXMO platform, which combines computational, structure-based design with synthetic chemistry to create cell-permeable compounds against difficult protein targets. Its lead programs are investigational and at discovery or preclinical stages.
$92.5MSeries E
ParticipantSavvy Wealth
Savvy Wealth gives independent financial advisors an operating platform that combines practice tools, investment support and AI-assisted client work.
$100MSeries C
ParticipantLeal Therapeutics
Develops neuro-metabolic therapeutics for schizophrenia and ALS
$30MSeries A
Role not disclosedInduPro
Develops proximity-guided antibody-drug conjugate therapeutics for cancer and autoimmune disease
$77MSeries B
Role not disclosed